Results 41 to 50 of about 94,986 (281)

Tularemia live vaccine as a modifier of genotoxic and carcinogenic action of environmental factors [PDF]

open access: yesArchive of Oncology, 2002
In this review we presented the data concerning the influence of tularemia live vaccine (TLV, produced in the USSR and Russia) on mutagenesis and carcinogenesis.
Nersesyan Armen K.   +2 more
doaj   +1 more source

The History, Present and Future of Allergen Standardization in the United States and Europe

open access: yesFrontiers in Immunology, 2021
The topic of standardization in relation to allergen products has been discussed by allergists, regulators, and manufacturers for a long time. In contrast to synthetic medicinal products, the natural origin of allergen products makes the necessary ...
Julia Zimmer   +5 more
doaj   +1 more source

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges. [PDF]

open access: yes, 2019
Introduction: Tuberculosis (TB) remains a major health threat and it is now clear that the current vaccine, BCG, is unable to arrest the global TB epidemic. A new vaccine is needed to either replace or boost BCG so that a better level of protection could
Barclay WR   +8 more
core   +1 more source

A stable live bacterial vaccine [PDF]

open access: yesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2016
Formulating vaccines into a dry form enhances its thermal stability. This is critical to prevent administering damaged and ineffective vaccines, and to reduce its final cost. A number of vaccines in the market as well as those being evaluated in the clinical setting are in a dry solid state; yet none of these vaccines have achieved long-term stability ...
Nitesh K. Kunda   +4 more
openaire   +3 more sources

Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products

open access: yesViruses, 2015
Live biotherapeutic products (LBPs), commonly referred to as probiotics, are typically preparations of live bacteria, such as Lactobacillus and Bifidobacterium species that are considered normal human commensals.
Sheila M. Dreher-Lesnick   +2 more
doaj   +1 more source

A NOTE ON THE PREPARATION OF BACTERIAL VACCINES [PDF]

open access: yesJournal of the American Medical Association, 1914
The work of Vaughan, his associates and others interested in protein poisons has established the relationship of these substances to local and general anaphylactic reactions. Some of the reactions following the injection of bacterial vaccines are undoubtedly due to extraneous medium proteins which have not been removed from the bacterial suspensions in
openaire   +2 more sources

A Comprehensive Review on Bacterial Vaccines Combating Antimicrobial Resistance in Poultry

open access: yesVaccines, 2023
Bacterial vaccines have become a crucial tool in combating antimicrobial resistance (AMR) in poultry. The overuse and misuse of antibiotics in poultry farming have led to the development of AMR, which is a growing public health concern.
Md. Saiful Islam, Md. Tanvir Rahman
doaj   +1 more source

Mycobacterium tuberculosis sulfurtransferase SseA is activated by its neighboring gene product Rv3284

open access: yesFEBS Letters, EarlyView.
Tuberculosis remains a global health challenge and new therapeutic targets are required. Here, we characterized SseA, a sulfurtransferase from Mycobacterium tuberculosis involved in macrophage infection, and its interaction with the newly identified protein SufEMtb that activates SseA enzymatic activity.
Giulia Di Napoli   +10 more
wiley   +1 more source

A SpA+LukAB vaccine targeting Staphylococcus aureus evasion factors restricts infection in two minipig infection models

open access: yesnpj Vaccines
Staphylococcus aureus is a major cause of bacterial infection-related deaths. Increasing antimicrobial resistance highlights the urgent need for effective preventative strategies.
Jan T. Poolman   +18 more
doaj   +1 more source

Clinical trial of tolerability, safety and immunogenicity of influenza inactivated split-vaccine Flu-M in children aged 6 to 17 years

open access: yesЖурнал инфектологии
Purpose. To evaluate the tolerability, safety and immunogenicity of influenza inactivated split flu vaccine Flu-M during single immunization of children aged 6 to 17 years.Materials and methods.
A. M. Korolyuk   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy